Ambassador Susan C. Schwab

Ambassador Schwab served as U.S. Trade Representative (2006–09) and as deputy (2005–06).

As USTR, she concluded free trade agreements with Peru, Colombia, South Korea and others; and launched the Trans-Pacific Partnership (TPP) negotiations.  She pursued and/or settled trade disputes with various WTO members, including China, Canada, and the EU, and engaged in negotiations at the WTO, APEC and other multilateral institutions.

In academia, she served as dean of the School of Public Policy at the University of Maryland; and as vice chancellor of the University System of Maryland (USM) & CEO of the USM Foundation.  She still teaches classes in international trade.

In the private sector, Schwab was director of corporate business development for Motorola, Inc., where she engaged in M&A and joint venture negotiations in Asia, including in China.

Earlier in government, she served as assistant secretary of Commerce and director-general of the U.S. & Foreign Commercial Service, as a trade staffer and legislative director for Senator John C. Danforth (R-MO), and as a foreign service officer at the US Embassy in Tokyo.  She began her career as an agricultural trade negotiator at USTR.

Ambassador Schwab serves on the boards of Caterpillar, FedEx and Marriott, as well as The Conference Board, Business Council for International Understanding (BCIU), Lee Kuan Yew School of Public Policy, and Signature Theatre of Arlington, VA.  She chairs the board of The National Foreign Trade Council (NFTC).

She holds a BA from Williams College; a Master’s from Stanford University; and a Ph.D. from The George Washington University.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More